Newly developed pseudogout arthritis after therapy with MAGE-A4 directed TCR T cells responded to treatment with tocilizumab

por Kim, Sang T., Tayar, Jean, Fu, Siqing, Ke, Danxia, Norry, Elliot, Sun, Amy, Miller, Juli, Hong, David S.
Publicado 2021

Durable control of metastases in an HLA-A2+ patient with refractory melanoma after low-dose radiotherapy in combination with MAGE-A4 T cell therapy: a case report

por He, Kewen, Hong, David S., Ke, Danxia, Kebriaei, Partow, Wang, Tianjiao, Danesi, Hassan, Bertolet, Genevieve, Leuschner, Carola, Puebla-Osorio, Nahum, Voss, Tiffany A., Lin, Quan, Norry, Elliot, Fracasso, Paula M., Welsh, James W.
Publicado 2023

Tuning T‐Cell Receptor Affinity to Optimize Clinical Risk‐Benefit When Targeting Alpha‐Fetoprotein–Positive Liver Cancer

por Docta, Roslin Y., Ferronha, Tiago, Sanderson, Joseph P., Weissensteiner, Thomas, Pope, George R., Bennett, Alan D., Pumphrey, Nicholas J., Ferjentsik, Zoltan, Quinn, Laura L., Wiedermann, Guy E., Anderson, Victoria E., Saini, Manoj, Maroto, Miguel, Norry, Elliot, Gerry, Andrew B.
Publicado 2019

Phase 1 Clinical Trial Evaluating the Safety and Anti-Tumor Activity of ADP-A2M10 SPEAR T-Cells in Patients With MAGE-A10+ Head and Neck, Melanoma, or Urothelial Tumors

por Hong, David S., Butler, Marcus O., Pachynski, Russell K., Sullivan, Ryan, Kebriaei, Partow, Boross-Harmer, Sarah, Ghobadi, Armin, Frigault, Matthew J., Dumbrava, Ecaterina E., Sauer, Amy, Brophy, Francine, Navenot, Jean-Marc, Fayngerts, Svetlana, Wolchinsky, Zohar, Broad, Robyn, Batrakou, Dzmitry G., Wang, Ruoxi, Solis, Luisa M., Duose, Dzifa Yawa, Sanderson, Joseph P., Gerry, Andrew B., Marks, Diane, Bai, Jane, Norry, Elliot, Fracasso, Paula M.
Publicado 2022

Phase I clinical trial evaluating the safety and efficacy of ADP-A2M10 SPEAR T cells in patients with MAGE-A10(+) advanced non-small cell lung cancer

por Blumenschein, George R, Devarakonda, Siddhartha, Johnson, Melissa, Moreno, Victor, Gainor, Justin, Edelman, Martin J, Heymach, John V, Govindan, Ramaswamy, Bachier, Carlos, Doger de Spéville, Bernard, Frigault, Matthew J, Olszanski, Anthony J, Lam, Vincent K, Hyland, Natalie, Navenot, Jean-Marc, Fayngerts, Svetlana, Wolchinsky, Zohar, Broad, Robyn, Batrakou, Dzmitry, Pentony, Melissa M, Sanderson, Joseph P, Gerry, Andrew, Marks, Diane, Bai, Jane, Holdich, Tom, Norry, Elliot, Fracasso, Paula M
Publicado 2022

Autologous T cell therapy for MAGE-A4(+) solid cancers in HLA-A*02(+) patients: a phase 1 trial

por Hong, David S., Van Tine, Brian A., Biswas, Swethajit, McAlpine, Cheryl, Johnson, Melissa L., Olszanski, Anthony J., Clarke, Jeffrey M., Araujo, Dejka, Blumenschein, George R., Kebriaei, Partow, Lin, Quan, Tipping, Alex J., Sanderson, Joseph P., Wang, Ruoxi, Trivedi, Trupti, Annareddy, Thejo, Bai, Jane, Rafail, Stavros, Sun, Amy, Fernandes, Lilliam, Navenot, Jean-Marc, Bushman, Frederic D., Everett, John K., Karadeniz, Derin, Broad, Robyn, Isabelle, Martin, Naidoo, Revashnee, Bath, Natalie, Betts, Gareth, Wolchinsky, Zohar, Batrakou, Dzmitry G., Van Winkle, Erin, Elefant, Erica, Ghobadi, Armin, Cashen, Amanda, Grand’Maison, Anne, McCarthy, Philip, Fracasso, Paula M., Norry, Elliot, Williams, Dennis, Druta, Mihaela, Liebner, David A., Odunsi, Kunle, Butler, Marcus O.
Publicado 2023